(Adnkronos) - “Dal 2020 è stato avviato un programma nazionale di screening per l'infezione da Hcv che è destinato a 3 popolazioni target - le persone nate dal 1969 al 1989; quelle che accedono ai servizi pubblici di dipendenza, i Sert, e per le persone detenute in carcere - con un finanziamento di oltre 70 milioni di euro”. Lo ha detto Anna Caraglia, dirigente sanitario medico per la direzione generale della Prevenzione Sanitaria del Ministero della Salute, partecipando al convegno su “Epatite C: Obiettivo eliminazione, il momento è adesso. Strategie e modelli organizzativi per riscrivere la storia delle epatiti virali”, organizzato a Roma.
Category
🗞
NewsTranscript
00:00Since 2020, a national screening program has been launched for HCV infections,
00:11which is intended for three target populations.
00:15For people born from 1969 to 1989,
00:19for people who access public services for employment,
00:23SERDs, and for people detained in prison.
00:27This program has been financed with over 70 million euros.
00:34It is an important program for public health,
00:38as it has allowed to screen over 2 million people
00:44and to identify over 13,700 cases of active hepatitis infection.
00:51These people have had access to therapy,
00:54which means the elimination of infection and complications due to the disease,
01:00as well as the interruption of the chain of transmission of the infection.
01:04It is an important program,
01:07as it meets the international guidelines for the elimination of hepatitis disease by 2030.
01:18Today's event is important,
01:21as we will be able to gather instances from the regions and autonomous provinces.
01:27The importance of the regions is fundamental for the implementation of this program.
01:33Considering that some regions have not yet provided the data that the Ministry has requested,
01:40and above all to achieve the objectives set by international organizations,
01:47we have not yet reached the optimal data
01:51requested by the Ministry of Health
01:55through the screening decree for the HCV in Italy.